|
CXADR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.242000E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.080100E-03 |
| Normal-vs-Stage2 |
1.312030E-02 |
| Normal-vs-Stage3 |
1.93818999999484E-05 |
| Normal-vs-Stage4 |
7.71750000000404E-05 |
| Stage1-vs-Stage2 |
8.136200E-01 |
| Stage1-vs-Stage3 |
8.893800E-02 |
| Stage1-vs-Stage4 |
7.139700E-02 |
| Stage2-vs-Stage3 |
4.297400E-01 |
| Stage2-vs-Stage4 |
3.172800E-01 |
| Stage3-vs-Stage4 |
7.149600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.387300E-04 |
| Normal-vs-AfricanAmerican |
7.089800E-01 |
| Normal-vs-Asian |
1.457010E-03 |
| Caucasian-vs-AfricanAmerican |
1.552000E-01 |
| Caucasian-vs-Asian |
5.486400E-01 |
| AfricanAmerican-vs-Asian |
1.103400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.63886999999807E-05 |
| Normal-vs-Female |
2.038700E-03 |
| Male-vs-Female |
5.460100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.420400E-03 |
| Normal-vs-Age(41-60Yrs) |
7.226900E-04 |
| Normal-vs-Age(61-80Yrs) |
1.169690E-04 |
| Normal-vs-Age(81-100Yrs) |
4.819600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.786200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.077160E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.219800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.682200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.115000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.703000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.900340E-02 |
| Classical-VS-Follicular |
1.707930E-02 |
| Classical-VS-Other |
7.466100E-02 |
| Classical-VS-Normal |
6.640100E-03 |
| Tall-VS-Follicular |
9.921800E-01 |
| Tall-VS-Other |
1.546570E-01 |
| Tall-VS-Normal |
9.94009999999435E-05 |
| Follicular-VS-Other |
3.934600E-01 |
| Follicular-VS-Normal |
2.208100E-04 |
| Other-VS-Normal |
4.424400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.89350000000222E-05 |
| Normal-vs-N1 |
2.595200E-04 |
| N0-vs-N1 |
5.834800E-01 |
|
|
